Table 1:
Study | Enrollment period | Location | FiO2 groups | Total eligible | Total included, N (%) | Total excluded as no HR available for the first two minutes after birth | No bradycardia | Transient bradycardia | Prolonged bradycardia |
---|---|---|---|---|---|---|---|---|---|
Wang et al | 2005-2007 | United States | 0.21 vs 1.0 | 37 | 27 (73%) | 10 (27%) | 14 | 5 | 8 |
Escrig et al | 2005-2007 | Spain | 0.3 vs 0.9 | 42 | 42(100%) | 0 (0%) | 2 | 25 | 15 |
Vento et al | 2007-2008 | Spain | 0.3 vs 0.9 | 78 | 78 (100%) | 0 (0%) | 18 | 2 | 58 |
Rabi et al | 2005-2007 | Canada | 0.21 vs 1.0 | 26 | 24 (92%) | 4 (8%) | 7 | 4 | 13 |
Aguar et al | 2010-2012 | Spain | 0.3 vs 0.6 | 60 | 60 (100%) | 0 (0%) | 14 | 24 | 22 |
Rook et al | 2018-2012 | Netherlands | 0.3 vs 0.6 | 139 | 61 (44%) | 78 (54%) | 44 | 4 | 13 |
Kapadia et al | 2010-2011 | United states | 0.21 vs 1.0 | 51 | 51 (100%) | 0 (0%) | 28 | 11 | 12 |
Oei et al | 2009-2014 | Australia Malaysia Qatar | 0.21 vs 1.0 | 287 | 262 (91%) | 25 (9%) | 127 | 47 | 88 |
Total | 720 | 605 (84%) | 115 (16%) | 254 | 122 | 229 |
No bradycardia: HR ≥ 100 bpm throughout the first 10 minutes. Transient bradycardia: HR below 100 bpm for < two minutes. Prolonged bradycardia: HR below 100 bpm for ≥ two minutes.